Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles.

Eitemau Tebyg

• Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease.
  gan: Kaplan, A H, et al.
  Cyhoeddwyd: (1994)
• Expression of active human immunodeficiency virus type 1 protease by noninfectious chimeric virus particles.
  gan: Kohl, N E, et al.
  Cyhoeddwyd: (1991)
• Human immunodeficiency virus type 1 virions composed of unprocessed Gag and Gag-Pol precursors are capable of reverse transcribing viral genomic RNA.
  gan: Kaplan, A H, et al.
  Cyhoeddwyd: (1994)
• Conditional human immunodeficiency virus type 1 protease mutants show no role for the viral protease early in virus replication.
  gan: Kaplan, A H, et al.
  Cyhoeddwyd: (1996)
• Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease.
  gan: Kempf, D J, et al.
  Cyhoeddwyd: (1991)